Difference between revisions of "Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2) (Q10987)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: named entity (P78): Hypertension (disease - MeSH descriptor) (Q8319), #quickstatements; #temporary_batch_1592937423256)
 
(4 intermediate revisions by the same user not shown)
Property / named entity
- 
Property / named entity: Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2) / rank
-
Normal rank
 
Property / named entity
- 
Property / named entity: COVID-19 (disease - MeSH supplementary concept) / rank
-
Normal rank
 
Property / named entity
 +
Property / named entity: Diabetes Mellitus (disease - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Heart Disease (disease - MeSH descriptor) / rank
 +
Normal rank
Property / Collection or Dataset of Origin
 +
Property / Collection or Dataset of Origin: Pubtator Central BioC-JSON formatted article files / rank
 +
Normal rank

Latest revision as of 23:39, 20 October 2020

Publication: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty"published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34 DOI: 10.1007/s11886-020-01293-2
Language Label Description Also known as
English
Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2)
Publication: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty"published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34 DOI: 10.1007/s11886-020-01293-2

    Statements

    0 references